Humalog Injection, Solution
Product Images NDC 50090-1375

Product Visual Gallery

This gallery contains 88 technical images submitted to the FDA as part of the official labeling for Humalog (NDC 50090-1375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Humalog 5sec Clock)

An instructional illustration showing a timer dial set to 5 seconds with the text '5 sec' below the dial, indicating a recommended wait or timing guideline.*

FDA Label Image

Figure (Humalog Qr)

Humalog KwikPen 100 units/mL injection, solution for intravenous or subcutaneous use. The label is from A-S Medication Solutions and features essential product identification details and a QR code likely used for product verification or information access.*

FDA Label Image

Figure 1 (Humalog F001 V3)

A line graph comparing blood glucose levels (mg/dL) over time (minutes) between Humalog and Humulin R insulin treatments. The x-axis shows time in minutes up to 480, and the y-axis shows blood glucose concentration ranging from 0 to 250 mg/dL. Two curves represent data for Humalog and Humulin R, with a legend indicating sample sizes and mean dose.*

FDA Label Image

Figure 2 (Humalog F003 V2)

A line graph comparing serum free insulin concentration (mU/L) over time (minutes) for Humalog and Humulin R at a mean dose of 15.4 units. The graph shows two curves representing insulin levels from 0 to 480 minutes, illustrating pharmacokinetic profiles of both insulin types.*

FDA Label Image

Figure (Humalog Inj Sites V1)

An anatomical illustration showing recommended injection sites for Humalog KwikPen (Insulin lispro) injection. The marked areas include the abdomen around the navel, the front thigh regions, and the upper outer buttock areas on a human figure viewed from the front and back.*

FDA Label Image

Figure (Humalog Jr Ifu 1 V1)

Humalog Junior KwikPen insulin lispro injection pen device for subcutaneous and intravenous use. The pen has a gray cap, a white and orange label with the Humalog Junior KwikPen branding, and a dose selector showing units. Manufactured by A-S Medication Solutions.*

FDA Label Image

Figure (Humalog Jr Ifu 10 V2)

Close-up image of a Humalog KwikPen insulin injection pen dosage window. The visible dose scale shows a calibration mark at 0.5 units, indicating dose increments for insulin lispro 100 units/mL solution. The pen features a gray dial and cap, consistent with its design by labeler A-S Medication Solutions.*

FDA Label Image

Figure (Humalog Jr Ifu 11 V2)

An instructional diagram showing a close-up view of a dosage window on an injection device with dose markings labeled 7, 8, and 9. A red arrow points upward from the side of the device, indicating a direction of movement or adjustment on the dose selector.*

FDA Label Image

Figure (Humalog Jr Ifu 12 V2)

An instructional illustration showing a close-up of a dial or dose selector on a Humalog KwikPen insulin injection device. The dial displays dose markings from 3 to 5 with an arrow pointing at the 4-unit mark, indicating dose setting functionality for insulin lispro administration.*

FDA Label Image

Figure (Humalog Jr Ifu 13 V2)

An illustration showing the dose selector window of the Humalog KwikPen insulin injection device, highlighting the dosage measurement scale with numbers and a red arrow pointing to the dose setting area.*

FDA Label Image

Figure (Humalog Jr Ifu 14 V3)

An instructional illustration showing a hand administering a subcutaneous injection in the abdominal area. The image depicts a syringe or pen injector being held and inserted under the skin near the side of the abdomen, demonstrating the technique for delivering an injection.*

FDA Label Image

Figure (Humalog Jr Ifu 15 V3)

An illustration showing a close-up view of the dose selector window and dose knob on a Humalog KwikPen insulin injection device. The dose window displays dose markings including 0 and 0.5 units, indicating the incremental dosing feature of the pen.*

FDA Label Image

Figure (Humalog Jr Ifu 16 V3)

An instructional illustration showing a hand holding a pen-style injection device with a protective cap being removed. An arrow indicates the direction to pull off the cap, presumably preparing the Humalog KwikPen insulin lispro injection for use.*

FDA Label Image

Figure (Humalog Jr Ifu 17 V3)

An illustration showing a hand holding a syringe with an insulin pen needle attached. The image highlights a twisting or peeling motion to remove the protective cover from the needle, depicted with a red arrow indicating the direction of rotation.*

FDA Label Image

Figure (Humalog Jr Ifu 18 V3)

An instructional illustration showing a Humalog KwikPen insulin injection pen with its cap removed, indicated by an arrow pointing away from the pen to the left. The pen is displayed horizontally with visible markings on the barrel and a needle end on the right.*

FDA Label Image

Figure (Humalog Jr Ifu 2 V1)

Illustration of the parts of the HUMALOG Junior KwikPen insulin lispro injection device, including detailed components such as the pen cap with cap clip, cartridge holder, rubber seal, plunger, label, pen body, dose knob with dose indicator and window. Also shows pen needle parts (not included) including outer needle shield, inner needle shield, needle, and paper tab, along with a separate view of the dose knob.*

FDA Label Image

Figure (Humalog Jr Ifu 3 V2)

An instructional diagram depicting a pen needle with an arrow pointing to the left, likely indicating the direction for removal or attachment related to the Humalog KwikPen insulin lispro injection device.*

FDA Label Image

Figure (Humalog Jr Ifu 4 V1)

An instructional illustration showing a hand gripping a cap with thumb and index finger, turning it counterclockwise as indicated by a curved red arrow, to remove the cap from a pen-like medical device. The image is relevant to preparation or use of an injection device such as the Humalog KwikPen insulin injection.*

FDA Label Image

Figure (Humalog Jr Ifu 5 V1)

Illustration showing a step to prepare a Humalog KwikPen injection device, depicting the removal of a cap by twisting it off. The image is part of the instructions for using the insulin lispro injection solution pen.*

FDA Label Image

Figure (Humalog Jr Ifu 6 V1)

An instructional diagram showing how to remove the needle shield from a Humalog KwikPen insulin injection pen. It illustrates keeping the outer needle shield and throwing away the inner needle shield before injection.*

FDA Label Image

Figure (Humalog Jr Ifu 7 V2)

An instructional illustration showing a close-up view of a Humalog KwikPen insulin injection device. The image highlights the dose window with visible dosage markings and a red arrow indicating the direction to turn or adjust the dose selector knob.*

FDA Label Image

Figure (Humalog Jr Ifu 8 V2)

An instructional illustration showing a hand holding a Humalog KwikPen insulin injection pen. Another hand is dialing or adjusting the dose on the pen, indicating how to set the dose before injection.*

FDA Label Image

Figure (Humalog Jr Ifu 9 V2)

An instructional diagram showing hands holding an insulin syringe vertically with the needle pointing up. A drop of liquid is shown at the needle tip, emphasized in a circular magnified inset, indicating priming or air removal from the syringe before injection.*

FDA Label Image

Primary Structure (Humalog Structure V1)

Chemical structure diagram depicting the amino acid sequences of the A-chain and B-chain of insulin lispro. The illustration shows the peptide bonds and disulfide linkages between amino acids labeled by their standard three-letter codes and sequence positions.*

FDA Label Image

Figure (Humalog Tp Ifu 1 V1)

Humalog Tempo Pen insulin lispro injection pen device with a blue body and white label displaying product name and insulin concentration. Label states 'For Single Patient Use Only' and includes dosing scale. No manufacturer visible in image.*

FDA Label Image

Figure (Humalog Tp Ifu 11 V1)

An instructional illustration showing a person administering an injection into the lower abdominal area using a pen-style device. The image highlights proper hand positioning and injection site, consistent with subcutaneous injection technique.*

FDA Label Image

Figure (Humalog Tp Ifu 12 V1)

Humalog KwikPen insulin injection, solution 100 [iU]/mL by A-S Medication Solutions. The image shows the pen device with a blue body, a dosage window displaying a dose setting, and a maroon-colored dial or cap at the end.*

FDA Label Image

Figure (Humalog Tp Ifu 13 V2)

Illustration showing a Humalog KwikPen insulin pen injector with a protective cap partially removed, indicated by a red arrow pointing left to right. The pen is blue with a white dosage window and a label on the side. This diagram visually demonstrates the removal of the cap prior to injection.*

FDA Label Image

Figure (Humalog Tp Ifu 2 V1)

An instructional diagram showing the parts of the Humalog Tempo Pen and pen needle components. Labeled pen parts include the pen cap with cap clip, rubber seal, cartridge holder with dose markings, plunger, pen body with a Humalog label, dose indicator, dose window, and dose knob. The pen needle parts include the outer needle shield, inner needle shield, needle, and paper tab. A separate view shows the dose knob front view.*

FDA Label Image

Figure (Humalog Tp Ifu 3 V2)

An instructional illustration showing the disconnection of a blue pen device from a white cartridge or syringe, with a red arrow pointing leftward to indicate the direction for removal or detachment.*

FDA Label Image

Figure (Humalog Tp Ifu 4 V1)

An instructional illustration showing a close-up of a Humalog KwikPen dose window with a red adjustment dial. The dose window displays selectable units ranging from 1 to 4.*

FDA Label Image

Figure (Humalog Tp Ifu 5 V2)

Illustration showing a hand holding a syringe-style pen labeled as Humalog KwikPen with a close-up of the dose knob, highlighting the adjustment of the dose setting for insulin lispro injection, 100 IU/mL.*

FDA Label Image

Figure (Humalog Tp Ifu 6 V1)

Image of a Humalog KwikPen insulin injector showing a close-up of the dose selector window. The device is predominantly blue with a maroon dose knob on the right side. The dose window displays dosage numbers used to set the insulin lispro delivery amount per injection.*

FDA Label Image

Figure (Humalog Tp Ifu 7 V1)

An instructional illustration showing a hand adjusting the dose selector on a Humalog KwikPen insulin injection device. The dial is marked with dosage units, and a red arrow indicates the action of turning the dose selector to set the desired insulin dose.*

FDA Label Image

Figure (Humalog Tp Ifu 8 V1)

An illustration showing a close-up of the dosage window and dose selector dial on a Humalog KwikPen insulin injection pen. The window displays dose markings, with an arrow pointing to set the dose level between 10 and 12 units on the pen's blue body and purple end cap.*

FDA Label Image

Figure (Humalog Tp Ifu 9 V1)

An instructional diagram showing a close-up of the dose window on a Humalog KwikPen insulin injection pen, indicating how to read the dose setting numbers. The image highlights the dosage setting between 24 and 26 units.*

FDA Label Image

Figure (Humalog U100 Ifu 1 V3)

Humalog KwikPen insulin lispro injection pen labeled for single patient use only. The pen is blue with a white and maroon label indicating the product name and usage. It is manufactured by A-S Medication Solutions and contains 100 units per mL insulin lispro solution for subcutaneous or intravenous injection.*

FDA Label Image

Figure (Humalog U100 Ifu 10 V2)

Illustration showing the dose selector window of the Humalog KwikPen insulin lispro injection pen, displaying a dose set to 10 units. The pen is blue with a removable cap.*

FDA Label Image

Figure (Humalog U100 Ifu 11 V2)

An instructional diagram showing a close-up of a Humalog KwikPen insulin injector. The image highlights the dosage window with markings from 7 to 10 units and an arrow indicating the direction to adjust or set the dose by sliding a blue component with a thumb.*

FDA Label Image

Figure (Humalog U100 Ifu 12 V2)

An instructional illustration showing a close-up view of a dial window on a Humalog KwikPen insulin injection device. The dial window displays dosage numbers with an arrow pointing to the selected dose, highlighting the mechanism for setting the insulin lispro injection dose.*

FDA Label Image

Figure (Humalog U100 Ifu 13 V2)

An illustration depicting the dosage window of a Humalog KwikPen insulin injection pen. The window shows a dial with numbers, and a red arrow pointing to the number 26, demonstrating how to read or set the insulin dose on the pen.*

FDA Label Image

Figure (Humalog U100 Ifu 16 V1)

An instructional illustration showing a person administering an injection with a Humalog KwikPen insulin pen into the abdominal area. The image depicts the proper hand positioning and injection site for subcutaneous insulin delivery.*

FDA Label Image

Figure (Humalog U100 Ifu 18 V1)

An instructional illustration showing a hand holding an insulin pen with a protective cap being removed by pulling it away from the pen. The pen displays dosage markings, indicating it is designed for administering insulin.*

FDA Label Image

Figure (Humalog U100 Ifu 19 V1)

An instructional illustration showing a hand holding a Humalog KwikPen insulin injection pen. The pen's dosing window is visible, displaying a dosage scale from 0 to 180 units. A red arrow indicates twisting or dialing action on the pen dose selector.*

FDA Label Image

Figure (Humalog U100 Ifu 2 V3)

An illustration diagram showing the parts of the Humalog KwikPen insulin lispro injection pen and its needle components. Labeled parts of the pen include the cap clip, pen clip, rubber seal, cartridge holder, plunger, label, pen body, dose indicator, dose knob, and dose window. The pen needle parts shown separately are the outer needle shield, inner needle shield, needle, and paper tab. The dose knob is depicted separately as well.*

FDA Label Image

Figure (Humalog U100 Ifu 20 V3)

An instructional illustration showing the removal of a blue cap from a Humalog KwikPen insulin lispro injection pen. The cap is being pulled off in the direction indicated by a red arrow, revealing the pen's injection dosage window and needle area.*

FDA Label Image

Figure (Humalog U100 Ifu 3 V2)

An instructional illustration showing the removal of the blue protective cap from the Humalog KwikPen insulin pen. A red arrow indicates pulling the cap away from the pen before use.*

FDA Label Image

Figure (Humalog U100 Ifu 4 V1)

An instructional illustration showing a hand holding a vial and another hand holding a syringe needle capped with a protective shield. An arrow indicates the motion to remove the protective needle cap from the syringe.*

FDA Label Image

Figure (Humalog U100 Ifu 5 V1)

An instructional illustration showing how to remove the outer cap from a Humalog KwikPen insulin injection pen by pulling it off, indicated by a red curved arrow.*

FDA Label Image

Figure (Humalog U100 Ifu 6 V1)

An instructional diagram showing the removal and disposal of needle shields from a pen injector. The left illustration indicates keeping the outer needle shield, the center shows discarding the inner needle shield, and the right depicts the needle attached to a Humalog KwikPen insulin lispro injection pen.*

FDA Label Image

Figure (Humalog U100 Ifu 7 V2)

An illustration showing a close-up of the Humalog KwikPen dose selector window with visible dose markings and a red arrow pointing upward, indicating how to adjust the insulin dose.*

FDA Label Image

Figure (Humalog U100 Ifu 8 V2)

An instructional illustration showing a hand holding a syringe with markings and another hand adjusting or preparing the syringe. The image visually demonstrates a step in the use or preparation of an injection device or medication syringe.*

FDA Label Image

Figure (Humalog U100 Ifu 9 V2)

An instructional illustration showing a person holding a Humalog KwikPen insulin injector. The image focuses on the injection process with an inset magnifying the needle tip entering the skin, indicating proper subcutaneous injection technique.*

FDA Label Image

Figure (Humalog U200 Ifu 1 V3)

Humalog KwikPen insulin lispro injection 100 units/mL, an injection solution for intravenous or subcutaneous use, shown as a prefilled pen injector. The pen is gray with a label indicating it is for single patient use only and delivers up to 200 units per milliliter. The manufacturer is A-S Medication Solutions.*

FDA Label Image

Figure (Humalog U200 Ifu 10 V2)

An instructional illustration depicting the use of a Humalog KwikPen insulin injection device. The image shows a hand holding the pen, with an arrow indicating the direction to push or press, and a zoomed-in view of the needle insertion area.*

FDA Label Image

Figure (Humalog U200 Ifu 11 V1)

The image shows a dose window of a Humalog KwikPen insulin injection device calibrated in units, used for subcutaneous or intravenous administration. The dial indicates adjustable dose settings up to 10 units. The pen is labeled for insulin lispro, 100 IU/mL, by A-S Medication Solutions.*

FDA Label Image

Figure (Humalog U200 Ifu 12 V2)

An instructional illustration showing a close-up view of a hand holding a Humalog KwikPen insulin injection device, with an arrow indicating the step to remove the pen cap before injection.*

FDA Label Image

Figure (Humalog U200 Ifu 13 V3)

An instructional diagram showing a zoomed-in view of the dose indicator window on a Humalog KwikPen insulin injection device, highlighting the number 12 on the dose scale. The pen is designed for subcutaneous or intravenous injection of insulin lispro 100 units/mL.*

FDA Label Image

Figure (Humalog U200 Ifu 14 V2)

Close-up illustration of a dosing window on a Humalog KwikPen insulin injection device. The window shows dosage markings with numbers indicating insulin units, highlighted by a red arrow pointing to the set dose between 24 and 26 units.*

FDA Label Image

Figure (Humalog U200 Ifu 16 V2)

An instructional illustration showing a person injecting insulin solution subcutaneously into the abdomen using a syringe. The image focuses on the injection technique for subcutaneous administration.*

FDA Label Image

Figure (Humalog U200 Ifu 19 V3)

An instructional diagram showing a hand removing the protective cap from a Humalog KwikPen insulin lispro injection pen. The illustration emphasizes the step of preparing the pen for use by pulling off the cap before administration.*

FDA Label Image

Figure (Humalog U200 Ifu 2 V1)

A warning label panel with yellow background and black text stating: 'DO NOT TRANSFER TO A SYRINGE SEVERE OVERDOSE CAN RESULT.' The label emphasizes the risk of overdose if the product is transferred improperly.*

FDA Label Image

Figure (Humalog U200 Ifu 20 V3)

An illustration showing a hand holding a Humalog KwikPen insulin pen injector. The pen is labeled with a yellow and white label, highlighting the injection device used for subcutaneous or intravenous administration of insulin lispro 100 units/mL.*

FDA Label Image

Figure (Humalog U200 Ifu 21 V3)

An illustration showing a Humalog KwikPen insulin injection pen with a removable cap. The image depicts how to pull off the cap from the pen prior to use, with an arrow indicating the direction of removal.*

FDA Label Image

Figure (Humalog U200 Ifu 3 V3)

An illustrated diagram of Humalog KwikPen parts showing labeled components including the pen cap with cap clip, rubber seal, cartridge holder with caution label, plunger, pen body with product label, dose window, dose indicator, and dose knob. It also includes the pen needle parts (not included) featuring outer and inner needle shields, needle, and paper tab.*

FDA Label Image

Figure (Humalog U200 Ifu 4 V2)

An instructional illustration showing a close-up of a pen needle being removed from a pen injector, indicated by a red arrow pointing left away from the needle. The pen injector is partially visible with a yellow warning label on it.*

FDA Label Image

Figure (Humalog U200 Ifu 5 V2)

An instructional illustration showing a hand removing or placing a small cap or cover on a pen device, indicating the action by a red curved arrow pointing upward. The image likely demonstrates part of the preparation or usage steps for an injection pen such as Humalog KwikPen.*

FDA Label Image

Figure (Humalog U200 Ifu 6 V2)

An instructional illustration showing the removal of protective tape from a Humalog KwikPen insulin lispro injection pen. The image depicts a close-up of the pen's needle area with a red arrow indicating the direction to pull the tape for removal, highlighting a step in pen preparation for injection.*

FDA Label Image

Figure (Humalog U200 Ifu 7 V2)

An instructional illustration showing a needle shield removal process for Humalog KwikPen insulin lispro injection. It shows the outer needle shield with an arrow to keep it, and the inner needle shield with an instruction to throw it away, indicating proper preparation before injection.*

FDA Label Image

Figure (Humalog U200 Ifu 8 V2)

An instructional diagram showing a close-up of a Humalog KwikPen dose selector window with dose numbers partially visible. A red arrow points upward, indicating the dial or dose setting mechanism for the insulin injection pen.*

FDA Label Image

Figure (Humalog U200 Ifu 9 V2)

An instructional illustration showing a person holding a Humalog KwikPen insulin injection device, demonstrating how to prepare or handle the pen. The image highlights the pen with a yellow label and the hands positioned for use.*

FDA Label Image

Figure (Humalog Vial Ifu 1 V5)

Humalog KwikPen injection solution vial labeled with Insulin lispro 100 units/mL, manufactured by A-S Medication Solutions. The vial features a protective cap and a rubber stopper beneath the cap. The vial label displays the brand name and concentration, indicating it is for subcutaneous or intravenous use.*

FDA Label Image

Figure (Humalog Vial Ifu 10)

An illustration showing hands drawing liquid from a vial into a syringe with an arrow indicating upward movement. A close-up view of the syringe shows volume markings up to 40 units, highlighting measurement detail.*

FDA Label Image

Figure (Humalog Vial Ifu 11)

An instructional illustration showing a hand holding an insulin vial and another hand withdrawing insulin into a syringe, indicating the correct technique for drawing insulin from a vial.*

FDA Label Image

Figure (Humalog Vial Ifu 12 V2)

An illustration showing front and back views of a human body with shaded areas indicating recommended injection sites for the product. Shaded regions include the abdomen, front and sides of the thighs, and the back of the upper arms and buttocks.*

FDA Label Image

Figure (Humalog Vial Ifu 13)

Instructional illustration showing the correct technique for administering an injection into the abdominal area. The image depicts a hand holding a syringe and injecting into the abdomen with an arrow indicating the direction or location for injection.*

FDA Label Image

Figure (Humalog Vial Ifu 14)

An instructional illustration showing a person administering an injection in the abdominal area. The injection is given with a syringe, held at the side of the abdomen just above the waistline, demonstrating the subcutaneous injection technique.*

FDA Label Image

Figure (Humalog Vial Ifu 15)

An instructional diagram showing a hand administering an injection to a person's abdomen. The image illustrates the use of a syringe for subcutaneous injection into the abdominal area.*

FDA Label Image

Figure (Humalog Vial Ifu 2 V3)

An instructional diagram of a syringe showing its labeled parts: needle shield, needle, plunger tip, syringe body, and plunger. It highlights a zoomed-in view of the plunger tip registration at 20 units dose, demonstrating how to read an example dose on the syringe body.*

FDA Label Image

Figure (Humalog Vial Ifu 3)

An instructional illustration showing a hand holding a vial with the other hand removing or twisting off the vial cap. The image depicts how to open the vial, likely for preparing an injection.*

FDA Label Image

Figure (Humalog Vial Ifu 4)

An instructional illustration showing a hand removing a cap from a small vial. The image appears to demonstrate the initial step in preparing an injectable solution, likely related to the use of Humalog KwikPen (Insulin lispro) injection.*

FDA Label Image

Figure (Humalog Vial Ifu 5)

An instructional illustration showing hands holding a syringe, with an arrow indicating downward movement of the plunger. An inset displays a close-up of the syringe barrel marked with quantity graduations from 0 to 40 units.*

FDA Label Image

Figure (Humalog Vial Ifu 6)

An instructional diagram showing a hand inserting a syringe needle into a Humalog KwikPen insulin pen device. An arrow indicates the direction of needle insertion, demonstrating proper assembly for injection.*

FDA Label Image

Figure (Humalog Vial Ifu 7)

An instructional illustration showing hands using a syringe to draw or inject solution from a pen device. One hand holds the pen steadily while the other hand pulls or pushes the syringe plunger. A directional arrow indicates the motion of the syringe's plunger.*

FDA Label Image

Figure (Humalog Vial Ifu 8)

An instructional illustration showing a hand holding a vial and another hand drawing liquid into a syringe, with an inset close-up of the syringe barrel marked with volume measurements up to 40 units. The image likely demonstrates the correct technique for preparing an injection dose of Humalog KwikPen (insulin lispro) injection solution.*

FDA Label Image

Figure (Humalog Vial Ifu 9)

An instructional illustration depicting a person using a syringe to withdraw medication from a vial. The image shows hands holding the vial upside down and drawing the solution into the syringe, demonstrating proper technique for preparing an injection.*

FDA Label Image

Label Image (Lbl500901375)

Humalog KwikPen Insulin Lispro Injection 100 units/mL label, 10 mL vial, from A-S Medication Solutions. The label states the product contains 100 units of insulin lispro per mL, with refrigeration required and instructions to see the package insert. The label includes lot and product numbers, and the NDC 50090-1375-0.*

FDA Label Image

Label Image (Lbl500901663)

Label of Humalog KwikPen U-100 injection solution by A-S Medication Solutions. The label states the concentration as 100 units per mL of insulin lispro. It includes packaging information indicating the product contains 5 prefilled pens of 3 mL each. Instructions note refrigeration and a caution not to freeze.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.